Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Amarantus Bioscience Holdi AMBS
Posted On: 07/14/2014 9:13:51 AM
Post# of 30066
Avatar
Posted By: Mauibound
Conclusions
"The LymPro test, which measures mitogenic response to peripheral blood lymphocytes, demonstrates acceptable pre- analytical and analytical variation in this study. The test will transition into multiple clinical studies for differentiation of individuals at risk for Alzheimer’s Disease from other dementias."


It doesn't say, The test, may/could be used to/might, transition... It says WILL

Done deal.














(0)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site